For many women, hormonal fluctuations throughout life – from menstruation to menopause – can significantly impact mood, focus, and emotional wellbeing. Though,these shifts can be particularly pronounced,and frequently enough overlooked,in women with attention-deficit/hyperactivity disorder (ADHD). Emerging research highlights a crucial connection between hormonal changes and ADHD symptoms,prompting a reevaluation of diagnostic practices and treatment strategies to better support the millions of women affected.
Many women experience fluctuations in concentration, emotional regulation, and resilience at different points in life, or during their menstrual cycle. These shifts, often linked to hormonal changes, can be particularly pronounced in women with attention-deficit/hyperactivity disorder (ADHD). Understanding the interplay between hormones and ADHD is crucial for improving diagnosis and treatment for millions of women.
While ADHD is often identified in boys and men during childhood, it frequently goes unrecognized in girls and women. This is partly because symptoms can manifest differently and vary in intensity throughout the menstrual cycle, pregnancy, or menopause. These fluctuating symptoms can make diagnosis more challenging.
Research suggests that even small hormonal changes can have a significant impact on women with ADHD, leading to more noticeable “outliers” in mood, concentration, and stress response compared to women without the condition.
Hormones, Mood, and Focus: A Complex Connection
Table of Contents
Female sex hormones, particularly estrogen, play a central role in this dynamic. Estrogen influences brain chemicals like dopamine and serotonin, which are vital for concentration, motivation, and emotional stability. When estrogen levels decline – such as during the latter half of the menstrual cycle, after childbirth, or in menopause – this delicate balance can be disrupted, increasing sensitivity to stress and emotional challenges.
According to Swedish psychiatrist Lotta Borg Skoglund, who specializes in ADHD and ADS in girls and women, symptoms can intensify during these phases. “Affected individuals often report increased distractibility, reduced stress tolerance, heightened emotionality, and more sleep problems,” she says.
The connection lies in dopamine, a neurotransmitter essential for attention, motivation, and emotional regulation. Insufficient dopamine levels can make it difficult to focus, manage internal tension, or complete tasks. Individuals with ADHD have alterations in their dopamine systems, potentially leading to less effective dopamine availability – not necessarily a lack of the neurotransmitter itself, but rather faster breakdown or inefficient utilization.
This can explain why those with ADHD may be impulsive, easily distracted, or experience greater emotional swings.
How Estrogen Boosts Dopamine
Medications commonly used to treat ADHD aim to increase the availability of dopamine and noradrenaline in the brain, improving concentration, drive, and emotional stability. “Dopamine helps control many of our everyday behaviors, including some of the more problematic ones. Through the release of dopamine, we experience feelings of energy and joy,” explains Borg Skoglund. “It’s motivating and ensures we start and continue tasks.”
Estrogen further influences this process by impacting the dopamine system in several ways. It can stimulate dopamine production, promote its release, and slow its breakdown. “Estrogen is a true dopamine booster,” says Matthias Rudolph, a specialist in psychosomatic medicine and psychotherapy. Consequently, lower estrogen levels can lead to reduced dopamine availability, which can be particularly noticeable in women with ADHD.
Increased PMS and PMDS Risk
This hormonal influence is particularly evident during the menstrual cycle. In the first half, estrogen dominates, supporting dopamine production. However, in the second half, estrogen levels decrease while progesterone rises, shifting the hormonal balance and potentially reducing dopamine availability. This phase can make it harder for many women to manage their daily routines and increase their vulnerability to premenstrual syndrome (PMS).
Studies show that women with ADHD are significantly more likely to experience PMS than those without the condition – with nearly half affected in some studies. Astrid Neuy-Lobkowicz describes PMS as “a small depression that repeats itself every month due to hormonal factors.”
For some, the symptoms are even more severe, leading to premenstrual dysphoric disorder (PMDS), which significantly impacts quality of life. While PMDS affects 3 to 8 percent of the general female population, women with ADHD may be at higher risk.
Treatment Options and Support
There are several approaches to managing PMS or PMDS. Rudolph recommends chasteberry (Monk’s pepper) as a natural remedy to alleviate symptoms. Doctors may also prescribe low-dose selective serotonin reuptake inhibitors (SSRIs), typically used for depression or anxiety, to be taken only during the days leading up to menstruation. Another option is to slightly increase the dosage of ADHD medication during this time by 5 to 10 milligrams.
Hormonal preparations, such as continuous birth control pills that eliminate menstruation and suppress cyclical fluctuations, may also be considered for women who tolerate them. Estrogen gel can also have a stabilizing effect.
Effective treatment requires close collaboration between healthcare providers.
ADHD Throughout Life Stages
During pregnancy, estrogen levels rise significantly, potentially altering ADHD symptoms. Decisions about reducing or pausing ADHD medication should be made individually, weighing the benefits and risks with a healthcare professional.
Borg Skoglund notes that pregnant women with ADHD often report feeling uncomfortable in their bodies, worrying about childbirth, and experiencing self-doubt about motherhood. Therefore, increased support during pregnancy and the postpartum period is crucial, including early screening, enhanced care from midwives, and access to medical professionals.
Following childbirth, estrogen levels drop sharply, potentially increasing the risk of depressive moods. Studies suggest that the rate of postpartum depression is higher in women with ADHD – ranging from 10 to 20 percent in the general population to as high as 60 percent in some studies of women with ADHD.
Given that ADHD tends to run in families, parents with the condition may have children who exhibit regulatory difficulties, such as excessive crying. Rudolph advises seeking support from organizations like Pro Familia and working closely with healthcare providers and insurance companies to ensure extended care for these families.
Diagnosis During Perimenopause and Menopause
Many women receive an ADHD diagnosis around the time of perimenopause and menopause. During this transition, the interplay of hormones changes: progesterone production declines, and estrogen levels fluctuate. This impacts serotonin and dopamine levels in the brain, affecting mood, motivation, and emotional stability.
These hormonal shifts can exacerbate mood swings and impair emotional regulation and stress tolerance. Some women report experiencing ADHD symptoms for the first time during menopause, according to Borg Skoglund.
“In these cases, a thorough evaluation of hormone replacement therapy is particularly important, considering potential contraindications,” says Rudolph. He emphasizes the need for close collaboration between gynecologists, therapists, and primary care physicians. Alongside medication, exercise, and mind-body practices like Tai Chi, yoga, and Qigong can be beneficial.
“Strategies like establishing fixed routines, getting enough sleep, exercising regularly, eating a healthy diet, and structured planning are especially important during hormonally turbulent phases,” says Borg Skoglund. Self-help groups and psychoeducation can also be helpful.
